Immunostimulatory oligoribonucleotides

Details for Australian Patent Application No. 2006318464 (hide)

Owner Coley Pharmaceutical Group, Inc. Coley Pharmaceutical GmbH

Inventors Lipford, Grayson B.; Forsbach, Alexandra; Vollmer, Joerg

Agent Spruson & Ferguson

Pub. Number AU-B-2006318464

PCT Pub. Number WO2007/062107

Priority 60/739,529 25.11.05 US; 60/778,989 03.03.06 US

Filing date 22 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 17 February 2011

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/062107 Priority application(s): WO2007/062107

17 February 2011 Application Accepted

  Published as AU-B-2006318464

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006318473-Internal combustion engine

2006318462-Multiplex digital immuno-sensing using a library of photocleavable mass tags